Skip to main content

Table 2 Results

From: Cardiovascular magnetic resonance assessment of the aortic valve stenosis: an in vivo and ex vivo study

Patient Aortic valve type CMR Aortic valve type surgery AVA in vivo by CMR (cm2) AVA ex vivo by CMR (cm2) AVA by TEE (cm2) AVA by TTE (cm2) AVA by CATH (cm2) PG mean by Doppler (mmHg) PG mean by CATH (mmHg) LV EF by CMR (%) LV Mass by CMR (g) LV SV by CMR (ml)
1 BAV BAV 0.84 0.76 - 0.74 0.29 65 77 50 151 61
2 TAV TAV 0.70 0.55 0.65 0.65 0.36 59 65 41 126 36
3 TAV TAV 0.84 0.73 0.70 0.75 0.64 53 45 81 177 81
4 TAV TAV 0.86 0.70 0.80 0.75 0.52 76 76 59 178 73
5 TAV TAV 0.62 0.50 0.70 0.55 0.34 44 46 19 134 40
6 BAV BAV 0.76 0.69 1.10 0.65 0.85 40 35 45 210 72
7 TAV TAV 0.72 0.68 0.75 0.73 0.67 49 55 77 113 57
8 TAV TAV 0.71 0.59 0.80 0.69 1.08 30 20 71 120 50
  1. AVA, aortic valve area; BAV, bicuspid aortic valve; CMR, cardiovascular magnetic resonance; CATH, cardiac catheterization; TEE, transesophageal echocardiography; TTE, transthoracic echocardiography; LV EF, left ventricular ejection fraction; LV mass, left ventricular mass; LV SV, left ventricular stroke volume; PG, pressure gradient; TAV, tricuspid aortic valve